Trial intelligence / Profile preview

Effect of Bronchoscopy in Sepsis Patients With ARDS and VAP

NCT06072222Phase 2Completed

Sponsor
King Abdulaziz Specialist Hospital
Start
Jul 2020
Primary completion
Dec 2021
Countries
1
01

Overview

Phase 2, randomised, open-label trial (2 arms), sponsored by King Abdulaziz Specialist Hospital. Primary endpoints: Number of patients weaned from the ventilator at 2 weeks and Number of patients discharged from ICU at 2 weeks. Started Jul 2020; status: completed.

Beyond the preview

Go deeper on NCT06072222.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06072222.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call